𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stimulation in vitro of cells from patients with myeloproliferative disorders

✍ Scribed by Pegrum, G. D.

Publisher
Springer-Verlag
Year
1967
Weight
370 KB
Volume
14
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Relationship of thrombohemorrhagic compl
Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders
✍ W. R. Friedenberg; R. C. Roberts; D. E. David πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 646 KB

Thrombotic and hemorrhagic disorders are common complications of the myeloproliferative disorders. Endothelial cells release both procoagulant and profibrinolytic factors, which may contribute to these hemorrhagic or thrombotic complications. The pre-and postvenous stasis levels of the procoagulant

Correlations of JAK2–V617F mutation with
Correlations of JAK2–V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders
✍ Matthaios Speletas; Eirini Katodritou; Chrisoula Daiou; Eudokia Mandala; Emmanou πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 212 KB

Recently, the acquired mutation JAK2-V617F has been described in the majority of patients with myeloproliferative disorders (MPDs). In this study we evaluated its clinical and laboratory correlates in 166 patients with MPDs. The mutation was detected by allele-specific PCR in 119 patients: 81.4% (35